Teleflex (NYSE:TFX) Upgraded to Hold at UBS Group

UBS Group upgraded shares of Teleflex (NYSE:TFX) to a hold rating in a research report released on Tuesday,Zacks.com reports.

TFX has been the subject of a number of other reports. Bank of America raised Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price for the company in a report on Monday, April 13th. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. Mizuho boosted their price target on Teleflex from $140.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, July 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research report on Wednesday, June 24th. Finally, Truist Financial reiterated a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a research note on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Teleflex currently has a consensus rating of “Hold” and an average target price of $147.70.

Teleflex Stock Performance

NYSE TFX opened at $134.16 on Tuesday. The stock has a market cap of $5.94 billion, a P/E ratio of -5.88, a PEG ratio of 0.97 and a beta of 0.82. The company’s 50-day simple moving average is $130.88 and its 200 day simple moving average is $120.95. Teleflex has a twelve month low of $100.18 and a twelve month high of $139.67. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company’s quarterly revenue was up 32.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, research analysts forecast that Teleflex will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of TFX. Assenagon Asset Management S.A. bought a new stake in Teleflex during the 2nd quarter worth approximately $1,391,000. GAMMA Investing LLC increased its holdings in Teleflex by 60.7% during the 2nd quarter. GAMMA Investing LLC now owns 839 shares of the medical technology company’s stock valued at $106,000 after purchasing an additional 317 shares in the last quarter. Versant Capital Management Inc raised its position in Teleflex by 573.4% in the 2nd quarter. Versant Capital Management Inc now owns 431 shares of the medical technology company’s stock valued at $55,000 after purchasing an additional 367 shares during the last quarter. Glenmede Trust Co. NA raised its position in Teleflex by 42.1% in the 1st quarter. Glenmede Trust Co. NA now owns 6,867 shares of the medical technology company’s stock valued at $821,000 after purchasing an additional 2,036 shares during the last quarter. Finally, Bank of America Corp DE boosted its stake in Teleflex by 6.4% in the first quarter. Bank of America Corp DE now owns 445,958 shares of the medical technology company’s stock worth $53,341,000 after purchasing an additional 27,004 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.